Climate Change Data

AIM Vaccine Co., Ltd.

Climate Impact & Sustainability Data (2023)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:57,805.9 tCO2e/year
Scope 1 Emissions:212.30 tCO2e/year
Scope 2 Emissions:57,593.6 tCO2e/year
Total Energy Consumption:70,674,000 kWh/year
Water Consumption:865,000 m3/year
Waste Generated:175,000 tons/year (approx., including hazardous and non-hazardous)
Carbon Intensity:4,868.0 tons of CO2 equivalent/RMB100 million of revenue

ESG Focus Areas

  • Product Safety and Quality
  • Human Capital Development
  • Product Innovation and R&D
  • Corporate Governance
  • Compliance Operation
  • Anti-corruption and Anti-money Laundering
  • Intellectual Property Management
  • Employee Benefits and Rights
  • Responsible Marketing
  • Accessibility of Healthcare Service
  • Supplier Management
  • Information Safety and Privacy Protection
  • Energy Management
  • Community Investment
  • Hazardous Emissions and Wastes Management
  • Greenhouse Gas Emissions
  • Utilization of Resources
  • Water Resource Management
  • Public Charity
  • Ecological Environment Protection
  • Mitigation of Climate Change

Environmental Achievements

  • Waste gas discharge density decreased by 9.9% compared to the previous year
  • 100% compliance rate for gas emissions, solid waste emissions, and noise emissions

Social Achievements

  • Launched online learning platforms (AIM Classroom and AIM Knowledge Base), increasing average training duration per employee by 37.4% in 2023
  • Female employee inclusion at 49.8%, with 34.8% female managers
  • Supplied 246 million doses of HBV vaccine for the national immunization program
  • No corruption or other litigation and cases related to violations of business ethics

Governance Achievements

  • Established a corporate governance structure with the Board of Directors, Supervisory Committee, and Shareholders’ General Meeting
  • Established the Audit Committee, Remuneration and Appraisal Committee, Compliance and Risk Control Committee, Nomination Committee, and Strategy Committee
  • 100% director attendance rate at 11 Board of Directors meetings in 2023
  • No information security incidents or breaches in 2023
  • No corruption lawsuits filed against the Group and its employees in 2023

Climate Goals & Targets

Short-term Goals:
  • AIM Honesty to reduce solid waste and packaging waste by 1% in 2024

Environmental Challenges

  • Potential adverse impacts of extreme weather events on operations
  • Increased greenhouse gas discharge density by 14.8% compared to 2022
  • Increased usage of dry batteries due to cost-saving measures
  • Significant increase in paper usage due to increased production and documentation
Mitigation Strategies
  • Developed comprehensive emergency plans, including evacuation plans
  • Strengthened maintenance and upgrading of operational equipment
  • Improved procurement of dry batteries by selecting higher-quality ones
  • Promoting electronic document management system to reduce paper dependence

Supply Chain Management

Supplier Audits: 772 suppliers in 2023, with audits conducted regularly

Responsible Procurement
  • Supplier Management Regulations
  • Material Supplier Evaluation and Approval Procedures
  • Quality Risk Management Regulations
  • Interim Measures for Bidding and Tendering Management

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events (snowstorms, typhoons, rainstorms)

Reporting Standards

Frameworks Used: United Nations 2030 Agenda for Sustainable Development, Environmental, Social and Governance Reporting Guide (Hong Kong Stock Exchange)

UN Sustainable Development Goals

  • 3 Good Health and Well-Being
  • 4 Quality Education
  • 5 Gender Equality
  • 8 Decent Work and Economic Growth
  • 9 Industry, Innovation and Infrastructure
  • 10 Reduced Inequalities
  • 12 Responsible Consumption and Production
  • 16 Peace, Justice and Strong Institutions
  • 17 Partnerships for the Goals

The Group aligns its ESG management strategy with the UN SDGs, integrating them into daily operations and business activities.

Awards & Recognition

  • Most Investable Enterprise in China’s Pharmaceutical Industry for 2022
  • Excellent Case for High-Quality Development in the Big Health Industry by Xinhua News Agency for 2023
  • Star of Outstanding Achievements in Biomedical Enterprises for 2023
  • Top 100 Chinese Pharmaceutical Innovative Enterprises List for 2023
  • Top 100 Annual Growth Public Companies by Snowball for 2023
  • Outstanding Financial Team for 2023
  • Best Investor Relations Project Award and Best Digital Investor Relations Award for 2023